Kokilaben Dhirubhai Ambani Hospital, a pioneer in introducing the latest medical advancements and cutting-edge technologies in cancer care, proudly announced today the launch of its dedicated Hereditary Cancer Clinic at the International Symposium on Precision Oncology and Personalized Medicine organised by Kokilaben Hospital.

This ground-breaking clinic further cements Kokilaben Hospital's commitment to providing personalized cancer care to patients across India, marking a significant milestone in its journey to ensure access to state-of-the-art precision oncology care for every patient. It follows the pioneering efforts of Kokilaben Hospital in introducing personalized targeted cancer treatment, harnessing the power of precision medicine to deliver innovative therapies that effectively address individual patient needs.

The symposium also included a felicitation ceremony with Tina Anil Ambani, Chairperson of Kokilaben Hospital honoring eminent doctors and achievers in the field of oncology from across India and the world. Tina Anil Ambani said, "Cancer care is an overarching priority for Kokilaben Hospital, which has always been ahead of the curve in terms of technology and talent. We recognise that precision oncology and personalised medicine is the new frontier in cancer care and are delighted to host this symposium, which provides a wealth of information, a platform for deliberation, an opportunity for interaction and a forum to felicitate excellence. On this occasion, I am also delighted to announce that we are continuing to focus on precision oncology and personalised medicine, by launching a hereditary cancer clinic, which will help predict familial risk for cancer and take measures to control the same. This is one more significant step in our mission to 'Contain, Combat and Conquer Cancer'."

Dr. Santosh Shetty, CEO and Executive Director, Kokilaben Dhirubhai Ambani Hospital said, “Kokilaben Hospital has remained ahead of the curve and in line with the best global practices in cancer care. Our dedication to advancing personalized cancer care is evident in our commitment to investing in cutting-edge technology and research. The Hereditary Cancer Clinic demonstrates our relentless pursuit of excellence in Precision Oncology. With a multidisciplinary team of skilled experts, cutting-edge facilities, and the latest technologies, the addition of the new clinic is a testament to the largest commitment by any single institute in cancer, and is expected to make a significant difference in cancer outcomes.”